What do the latest advances in Alzheimer’s disease and dementia diagnostics mean for earlier, more informed neurodegenerative disease testing?

Alzheimer’s disease and related dementias are entering a new era of diagnostic possibility. As research uncovers more about the biological changes that occur long before symptoms appear, the field is moving beyond symptom-led assessment toward earlier, more pathology-informed approaches.

Blood-based biomarkers, automated assays, and robust research tools are helping to make this shift more practical. By supporting earlier detection and a deeper understanding of neurodegenerative disease biology, these advances are creating new opportunities for researchers, clinicians, and laboratories alike.

In this SelectScience^® Editorial Feature, discover expert insights, product resources, and emerging technologies shaping Alzheimer’s disease and dementia diagnostics. Explore how innovations in biomarker testing and neurodegenerative disease research are helping build more accessible, scalable, and clinically meaningful pathways for the future.